North American Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

North American Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,530	Closed	-$40K	–	111
2020 Q1	$40K	Hold	10,530	–	–	0.01%	107
2019 Q4	$32K	Buy	+10,530	New	+$27.4K	﹤0.01%	119

Other funds holding BMY.RT

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

North American Management's BMY.RT Position: Q2 2020 in Review

North American Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q2 2020, closing a stake of 10,530 shares — an estimated $40K sold.

North American Management first reported a position in BMY.RT in Q4 2019 and held it in 2 quarters. The position peaked at $40K in Q1 2020. 583 funds tracked by Wall St. Rank hold BMY.RT as of Q2 2020.

North American Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q2 2020 after selling out during the quarter.
North American Management sold 10,530 Bristol-Myers Squibb Company Contingent Value Rights shares in Q2 2020, an estimated $40K.
North American Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 2 quarters.
North American Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $40K in Q1 2020.
583 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q2 2020.

Based on North American Management's 13F filing for Q2 2020, filed 3 Aug 2020.